Evaluating Novo Nordisk: Insights From 8 Financial Analysts
Evaluating Novo Nordisk: Insights From 8 Financial Analysts
评估Novo Nordisk: 从8位金融分析师的见解中获得洞察力
The perception of Novo Nordisk by...Providing a diverse range of perspectives from bullish to bearish, 8 analysts have published ratings on Novo Nordisk (NYSE:NVO) in the last three months.
在过去三个月中，有8位分析师公布了诺和诺德（纽约证券交易所代码：NVO）的评级，提供了从看涨到看跌的不同视角。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表简要介绍了他们最近的收视率，展示了过去30天中不断变化的情绪，并将其与前几个月进行了比较。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $160.38, a high estimate of $163.00, and a low estimate of $160.00. This current average represents a 0.77% decrease from the previous average price target of $161.62.
分析师通过对12个月目标股价的评估提供了更深入的见解，显示平均目标价为160.38美元，最高估计为163.00美元，低估值为160.00美元。目前的平均价格比之前的平均目标价161.62美元下降了0.77％。
Investigating Analyst Ratings: An Elaborate Study
调查分析师评级：一项详尽的研究
The perception of Novo Nordisk by...
金融专家通过...
登录免费看全文
登录/注册
资讯热榜
更新时间